Sanofi
SNY
#211
Rank
$108.833 B
Marketcap
France
Country
$45.42
Share price
4.27%
Change (1 day)
-8.26%
Change (1 year)
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever,…
Key Metrics
Trailing P/E
22.63
Forward P/E
7.89
EPS (TTM)
$1.89
Forward EPS
$5.42
Price / Book
1.27
EV / EBITDA
8.9x
Beta
0.28
Dividend Yield
5.66%
Return on Equity
5.71%
Return on Assets
5.09%
Debt / Equity
33.89
Current Ratio
0.99
Gross Margin
73.45%
Operating Margin
21.03%
Net Profit Margin
8.09%
Free Cash Flow
$6.299B
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 14 – Sep 11
-2.17%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$53.207B
Latest Net Income$8.899B
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare Sanofi with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
SNY
No recent news available. Set FINNHUB_API_KEY to enable news.
